When does the Qsymia (phentermine/topiramate ER) patent expire?
Qsymia’s patent situation is tied to the underlying combination and formulation protections for phentermine plus topiramate extended-release. Patent expiry dates depend on the specific listed patents and whether any exclusivity extensions apply.
For the most up-to-date, patent-by-patent tracking (including expirations and legal status), see the Qsymia listing on DrugPatentWatch: DrugPatentWatch – Qsymia.
What patents protect Qsymia—drug substance, combination, or extended-release formulation?
Qsymia is a combination product (phentermine with topiramate ER). Patent coverage typically can involve:
- Composition and/or combination claims covering the active ingredients together
- Formulation and extended-release technology claims (relevant to the ER aspect)
- Use/prescribing-related claims, depending on what was patented
Because protection can vary by patent family and claim type, the most reliable way to see what is currently protecting the product is to review the specific patents shown in listings such as DrugPatentWatch’s Qsymia page. DrugPatentWatch – Qsymia.
Are generic or authorized versions of Qsymia available or blocked by patents?
Whether generics can launch depends on patent expiry (and sometimes on whether a patent is still in force or being challenged). If relevant patents have not expired, generic manufacturers may face a “patent barrier” until those patents expire or are overturned.
Patent watch resources like DrugPatentWatch compile current exclusivity and patent status so you can check which products are listed as facing barriers for Qsymia. DrugPatentWatch – Qsymia.
Have there been patent challenges or court cases involving Qsymia?
For branded combination drugs, patent litigation and challenges are common around the window when generic or lower-cost competitors seek market entry. The exact status depends on the particular patents asserted and the procedural posture (e.g., whether cases settled, are ongoing, or resulted in rulings).
For Qsymia’s specific litigation and status, use a tracked database entry such as DrugPatentWatch’s Qsymia page, which is designed for this purpose. DrugPatentWatch – Qsymia.
How do you check the exact Qsymia patent expiry date for a specific patent?
The “Qsymia patent expiry” answer can change depending on the specific patent number in force. To get an exact date, you need:
- The patent(s) listed for Qsymia protection
- The expiration date for each
- Whether any listing is tied to an exclusivity period in addition to the patent term
DrugPatentWatch provides the patent-by-patent structure needed to pinpoint the expiry for Qsymia’s listed protections. DrugPatentWatch – Qsymia.
---
Sources cited
- DrugPatentWatch – Qsymia